Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
about
Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survivalCross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic AcidsDiagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic reviewNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesMicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate CancerWhen Prostate Cancer Circulates in the BloodstreammicroRNA: Diagnostic PerspectiveThe circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluidsExtracellular microRNAs in urologic malignancies: chances and challengesNovel RNA markers in prostate cancer: functional considerations and clinical translationOxidative stress in prostate hyperplasia and carcinogenesisCirculating microRNAs: potential biomarkers for common malignanciesSelection and validation of reference genes for miRNA expression studies during porcine pregnancymiRNAs associated with prostate cancer risk and progressionmicroRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer.MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.Noncoding RNAs as novel biomarkers in prostate cancer.Serum microRNA is a promising biomarker for osteogenesis imperfectaCardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesmiR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancerNon-Coding RNAs: Functional Aspects and Diagnostic Utility in OncologyComprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis.Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer.Analysis of altered microRNA expression profiles in proximal renal tubular cells in response to calcium oxalate monohydrate crystal adhesion: implications for kidney stone disease.MicroRNAs as potential biomarkers in cancer: opportunities and challengesMiR-16 family as potential diagnostic biomarkers for cancer: a systematic review and meta-analysisMicroRNA (miRNA) in cancerMyc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanismsLinear Discriminant Functions in Connection with the micro-RNA Diagnosis of Colon CancerCirculating MicroRNA as Biomarkers: An Update in Prostate Cancer.Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study.Identification of novel microRNAs in Xenopus laevis metaphase II arrested eggs.A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk GroupmiR-1290 is a potential prognostic biomarker in non-small cell lung cancerPlasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection.miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
P2860
Q24294497-1C0C937D-E56E-44AC-8896-1A4F2A192693Q26744516-84039F40-322A-4741-9BD3-8FDA47C4C6CEQ26748872-001E5763-1674-4C1B-8F69-746D354C890FQ26748881-3BFFF634-A0F7-4117-8A95-B7FF1B8EE5EDQ26751983-71C59EC7-211A-452B-A914-3104CBCF4039Q26768470-7065B64D-6A79-4F82-BC26-004CBF14ADCCQ26797259-68D374A6-F9E4-4F7E-B5B5-AE9F51301639Q26825022-5B9C6316-8E04-4C15-A62D-C236C9E0688CQ26866043-31D1FA0F-8270-41B7-8536-07AB65327C1AQ27021174-1B1EF159-A5AF-494B-A2CC-39A483BEECCCQ28079474-86504E82-E4D0-4C4C-808C-A32E727AE93EQ28081347-93866FBC-0A1D-441C-94F0-8789A3478FDFQ28741578-C09F156C-0A53-46AB-9EAF-3C9ED3D2B47DQ30235186-A0905842-27FF-4046-9232-8FEDD2561E2EQ33853224-863D488C-1592-4A02-BCA5-5B9F69B8C2C3Q34045027-00E6F217-CB79-47BF-B4DD-F1370E609677Q34176890-580C7F5D-DAA8-4851-B4E9-2B9C53088A9DQ34377839-FE988314-AC78-4034-9162-BCB59A961B83Q34391443-677BCD22-969E-4E01-9C3C-2DD47CA1649FQ34544501-4636C953-5426-4941-9BF3-0EBAEA079EADQ34605730-54965FBA-A311-4867-89A2-F0141256C4F3Q34853050-2C3C71A1-A7F4-426E-A652-7DFE31D45C22Q35023641-70994898-E2EB-4448-939B-C62C841712ECQ35110766-AF427E9F-0798-4F15-BC90-C92BD988A7C2Q35140145-0DF01B5B-A2E7-45EC-B4B7-7B375D13B071Q35199169-48E78E47-FA15-4C76-BFEA-834E20F33B5DQ35271157-F1D241A8-0E05-4248-AF3E-2F91EAE7BB47Q35479266-A5B76960-4EDF-45EE-8357-68C75CA0C29DQ35583538-DACA4E7D-52C0-46E1-99E5-F70719B50DCEQ35640345-6FA6BDF9-E145-4B12-B25F-CFD09B2123BEQ35668983-BE273C80-8A9E-45DF-9F82-882C5116A0C5Q35780870-28BE0667-6653-4EF9-A1B1-79814054C569Q35814277-52E4ACAD-DAE2-4EED-868C-EC038C680425Q35841111-B8761059-CF6B-4D95-9015-87121C5198E9Q35844363-C63A573D-5EA6-4FB5-A861-12BC5D57343FQ35902208-5B6DCDBA-EF97-430B-8995-F17668C16E44Q36138340-5F59D63F-D643-4324-978E-EAAE0DD4CA4DQ36214432-AEBB77AA-491F-4530-A901-9D967193FF16Q36224827-6302EB3E-D1DE-4833-BD2A-766BF1DFC17CQ36244787-ADB8708F-D196-44AD-BAC1-FDF039659E75
P2860
Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
@ast
Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
@en
type
label
Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
@ast
Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
@en
prefLabel
Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
@ast
Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
@en
P2093
P1433
P1476
Circulating microRNAs (miRNA) in serum of patients with prostate cancer.
@en
P2093
Alexander von Ruecker
Jörg Ellinger
Robert Mahn
Sebastian Rogenhofer
Stefan C Müller
P304
1265.e9-16
P356
10.1016/J.UROLOGY.2011.01.020
P407
P577
2011-05-01T00:00:00Z